U2AF1 and chronic myelomonocytic leukemia: It is well known that more than 90% of patients with CMML have somatic mutations, with splicing factor mutations such as SRSF2, U2AF1, ZRSR2 and SF3B1 being highly prevalent, especially SRSF2 (20–24).